RxDoctor Payments Data

Travis Larson, MD

Family Medicine · Milton, FLNPI 1417482373

Payments from drug & device makers

$6,059in general payments, 2019–2025

Across 375 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$918
  • AbbVie$829
  • GSK$581
  • Lilly USA, LLC$462
  • AstraZeneca$385
  • Pfizer$381
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$6,059100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,059 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$193,274
Medicare patients
436
Services billed
3,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$93,292
OzempicSemaglutide67$89,751
MounjaroTirzepatide59$71,719
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$68,088
JardianceEmpagliflozin60$60,076
BiktarvyBictegrav/Emtricit/Tenofov Ala13$50,721
TrulicityDulaglutide36$46,641
FarxigaDapagliflozin Propanediol16$17,687
XareltoRivaroxaban14$13,868
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$11,950
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen389$10,045
Tresiba Flextouch U-100Insulin Degludec18$8,712
Janumet XrSitagliptin Phos/Metformin Hcl12$6,866
Atorvastatin Calcium381$5,789
Almotriptan Malate22$5,276

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$462$118,36095 claims
PfizerEliquis$381$93,29286 claims
Novo NordiskOzempic$918$89,75167 claims
GSKTrelegy Ellipta, Anoro Ellipta$581$80,03884 claims
Boehringer IngelheimJardiance$154$60,07660 claims
AstraZenecaFarxiga$385$17,68716 claims
Johnson & JohnsonXarelto$130$13,86814 claims
MerckJanumet Xr$100$6,86612 claims
AbbVieSynthroid$829$3,63057 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$55$3,46111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Milton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →